All Sauce from Weekly Sauce:

THURSDAY, Nov. 3, 2022 — U.S. doctors prescribing opioids for pain relief now have a new — and more nuanced — set of guidelines from the federal government. Issued by the U.S. Centers for Disease Control and Prevention on Thursday, the new recommendations incorporate new science developed since the last set of guidelines were released…  read on >  read on >

Out of the more than 25,000 U.S. cases of monkeypox reviewed in a new study, just 0.3% occurred in people under the age of 18, new government data shows. Most of the kids and teens who contracted the virus — 89% — “were not hospitalized, none received intensive care unit [ICU]-level care, and none died,”…  read on >  read on >

More than half of Americans aged 50 and up are helping an older adult manage tasks ranging from household chores to care for medical conditions, a new national poll shows. Researchers said the findings highlight the critical role that everyday people are playing in the lives of older family members, friends and neighbors. The results…  read on >  read on >

Autism is a more comprehensive disorder than previously thought, and appears to arise from brain changes located throughout the cerebral cortex, not just in specific areas, a new study reports. Because of autism’s specific symptoms, scientists had thought the disorder was likely caused by changes in brain regions believed to affect social behavior and language.…  read on >  read on >

Although blood pressure levels among Americans rose during the COVID-19 pandemic, new research suggests things could have been far worse. “We expected blood pressure control to be worse due to decreased physical activity, stress, poor sleep and other cardiovascular disease risk factors that worsened during the pandemic,” said study leader Dr. Hiroshi Gotanda, an assistant…  read on >  read on >

THURSDAY, Nov. 3, 2022 (HealthDay News) – A weight-loss drug approved for adults may soon become an option for teens struggling with obesity. Young people who received the drug Wegovy (semaglutide) were able to lose an average of 14.7% of their starting body weight in a new clinical trial. More than 40% of the youths…  read on >  read on >